6533b7d2fe1ef96bd125ed7a

RESEARCH PRODUCT

Role of RNA Motifs in RNA Interaction with Membrane Lipid Rafts: Implications for Therapeutic Applications of Exosomal RNAs

Teresa JanasKarolina SapońPawel JanasRafał MańkaTadeusz Janas

subject

liposomesFRET spectroscopyQH301-705.5AptamerRNA-binding proteinexosomesRNA motifsArticleCatalysisInorganic ChemistryMembrane LipidsMembrane MicrodomainsmicroRNAHumansRNA aptamersNucleotide MotifsBiology (General)Physical and Theoretical ChemistryNucleic acid structureQD1-999Molecular BiologyLipid raftSpectroscopyChemistryOrganic ChemistryRNAGeneral MedicineAptamers NucleotideNon-coding RNAMicrovesiclesComputer Science ApplicationsCell biologyChemistryNucleic Acid ConformationRNAlipids (amino acids peptides and proteins)

description

RNA motifs may promote interactions with exosomes (EXO-motifs) and lipid rafts (RAFT-motifs) that are enriched in exosomal membranes. These interactions can promote selective RNA loading into exosomes. We quantified the affinity between RNA aptamers containing various EXO- and RAFT-motifs and membrane lipid rafts in a liposome model of exosomes by determining the dissociation constants. Analysis of the secondary structure of RNA molecules provided data about the possible location of EXO- and RAFT-motifs within the RNA structure. The affinity of RNAs containing RAFT-motifs (UUGU, UCCC, CUCC, CCCU) and some EXO-motifs (CCCU, UCCU) to rafted liposomes is higher in comparison to aptamers without these motifs, suggesting direct RNA-exosome interaction. We have confirmed these results through the determination of the dissociation constant values of exosome-RNA aptamer complexes. RNAs containing EXO-motifs GGAG or UGAG have substantially lower affinity to lipid rafts, suggesting indirect RNA-exosome interaction via RNA binding proteins. Bioinformatics analysis revealed RNA aptamers containing both raft- and miRNA-binding motifs and involvement of raft-binding motifs UCCCU and CUCCC. A strategy is proposed for using functional RNA aptamers (fRNAa) containing both RAFT-motif and a therapeutic motif (e.g., miRNA inhibitor) to selectively introduce RNAs into exosomes for fRNAa delivery to target cells for personalized therapy.

https://doi.org/10.3390/ijms22179416